v3.26.1
License and Collaboration Agreement - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 06, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Collaboration revenue   $ 0 $ 0 $ 20,000,000 $ 0  
Accounts receivable   293,000   $ 293,000   $ 0
Tenacia License Agreement            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Agreement description       On March 6, 2026, the Company entered into the Tenacia License Agreement. The arrangement provides Tenacia with the exclusive rights to develop and commercialize the Company’s product candidate, RAP-219, in mainland China, Hong Kong, Macau and Taiwan (each, a “Market” and collectively, the “Tenacia Territory”). The Company retains exclusive rights to RAP-219 outside the Tenacia Territory.    
Upfront payment received $ 20,000,000          
Upfront payment 20,000,000          
Transaction price of performance obligation 20,000,000          
Collaboration revenue       $ 20,000,000    
Deferred revenue   0   0    
Incremental costs for financial advisory fees   2,000,000   2,000,000    
Contract assets related to costs to obtain contract with customer   $ 0   $ 0    
Tenacia License Agreement | Maximum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Contingent sales based milestone payments and tiered royalty payments $ 308,000,000